Compounded Tirzepatide — The Most Effective Weight Loss Option Available
Quick Answer
Compounded tirzepatide contains the same active ingredient as Mounjaro and Zepbound. In the SURMOUNT-1 trial, tirzepatide produced 21% average body weight reduction — significantly better than semaglutide's 15%. Marrow's compounded tirzepatide starts at $339/mo from an FDA-registered 503B pharmacy, vs $1,400+ for brand-name Mounjaro.
Tirzepatide is the most effective weight loss medication available today. Originally developed by Eli Lilly and sold as Mounjaro (for type 2 diabetes) and Zepbound (for weight management), tirzepatide produced weight loss results in clinical trials that were previously only seen with bariatric surgery. Compounded tirzepatide offers the same active ingredient through FDA-registered 503B pharmacies at a fraction of the brand-name cost.
The dual GIP + GLP-1 mechanism
Most weight loss medications in this class — including semaglutide (Ozempic/Wegovy) — activate a single receptor: GLP-1. Tirzepatide is fundamentally different. It simultaneously activates two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism is why it's called a “twincretin.”
GLP-1 activation suppresses appetite, slows gastric emptying, and improves blood sugar control. GIP activation enhances fat metabolism, improves lipid processing, and appears to reduce some of the GI side effects associated with GLP-1-only medications. Together, these pathways produce superior weight loss, better metabolic outcomes, and potentially improved tolerability.
Clinical evidence: the SURMOUNT-1 trial
The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, established tirzepatide as the most effective weight loss medication ever studied. Over 72 weeks, participants achieved:
Tirzepatide 5mg
15.0%
avg body weight loss
Tirzepatide 10mg
19.5%
avg body weight loss
Tirzepatide 15mg
20.9%
avg body weight loss
At the highest dose (15mg), participants lost an average of approximately 52 pounds. More than a third lost over 25% of their body weight. The placebo group lost 3.1%. These results were substantially better than semaglutide's 15% average in the STEP 1 trial.
Compounded tirzepatide vs semaglutide
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 only | GLP-1 + GIP (dual) |
| Avg weight loss | ~15% | ~21% |
| Brand names | Ozempic, Wegovy | Mounjaro, Zepbound |
| Marrow price | $249/mo | $339/mo |
| Brand price | $900-1,200/mo | $1,000-1,400/mo |
| Best for | First-time GLP-1, budget | Max results, plateaus |
Both are excellent options. Many patients start with semaglutide and upgrade to tirzepatide for greater results, while others start directly with tirzepatide for maximum efficacy. Your Marrow physician helps determine the right choice.
What is a 503B pharmacy?
503B pharmacies are compounding facilities registered with the FDA under Section 503B of the Federal Food, Drug, and Cosmetic Act. They operate under federal oversight and must follow Current Good Manufacturing Practice (cGMP) guidelines — the same quality standards as traditional pharmaceutical manufacturers. Every batch is tested for potency, purity, and sterility.
Marrow exclusively partners with FDA-registered 503B pharmacies. This means your compounded tirzepatide is manufactured to the same quality standards as brand-name medications, with full batch testing and FDA inspection oversight — at a fraction of the cost.
Who qualifies
Compounded tirzepatide may be appropriate for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea). During your Marrow intake, a licensed physician reviews your complete health history, current medications, and goals to determine if tirzepatide is the right fit.
Titration schedule
Tirzepatide is titrated gradually to minimize side effects and find your optimal dose. The standard schedule:
2.5mg weekly
Starting dose — adjustment period
5.0mg weekly
First dose increase
7.5mg weekly
Intermediate dose
10mg weekly
Therapeutic dose for most patients
12.5-15mg weekly
Maximum dose if needed
Your Marrow physician may adjust this schedule based on your tolerability and response. Not everyone needs to reach the maximum dose — many patients achieve excellent results at 10mg.
Cost comparison
| Option | Monthly cost | Annual cost |
|---|---|---|
| Brand Mounjaro/Zepbound | $1,000-1,400/mo | $12,000-16,800/yr |
| Marrow (compounded) | $339/mo | $4,068/yr |
| Potential savings | $661-1,061/mo | $7,932-12,732/yr |
Marrow's pricing includes everything: compounded tirzepatide from an FDA-registered 503B pharmacy, physician oversight, all injection supplies, dosage adjustments, and free shipping. No hidden fees. No insurance required.
View full pricing details or explore all weight loss treatment options.
How to start
Complete your intake
A quick 5-minute questionnaire about your health history, current medications, and goals.
Physician review
A licensed physician reviews your intake within 24 hours and discusses whether tirzepatide is the right fit.
Prescription ships
Your compounded tirzepatide is prepared by an FDA-registered 503B pharmacy and shipped to your door in 3-5 days.
Frequently asked questions
Is compounded tirzepatide the same as Mounjaro?
Compounded tirzepatide contains the same active pharmaceutical ingredient as Mounjaro and Zepbound. The difference is manufacturing: Mounjaro is produced by Eli Lilly, while compounded tirzepatide is prepared by FDA-registered 503B compounding pharmacies. The active ingredient, mechanism of action, and clinical effects are identical.
Why is compounded tirzepatide so much cheaper?
Brand-name Mounjaro and Zepbound include the cost of Eli Lilly's R&D, marketing, and brand markup — resulting in prices of $1,000-1,400/month. Compounded tirzepatide from 503B pharmacies uses the same pharmaceutical-grade active ingredient without the brand-name overhead, allowing significantly lower pricing. Marrow's compounded tirzepatide starts at $339/mo.
Is compounded tirzepatide legal?
Yes. Compounding is a well-established, FDA-recognized practice. 503B compounding pharmacies are registered with the FDA and operate under federal oversight. They can prepare compounded versions of medications when there is a clinical need, following the same Current Good Manufacturing Practice (cGMP) guidelines as traditional manufacturers.
How do I know the compounded tirzepatide is high quality?
Marrow partners exclusively with FDA-registered 503B pharmacies that undergo regular FDA inspections, test every batch for potency and purity, and follow cGMP guidelines. These are the same quality standards that apply to traditional pharmaceutical manufacturers. Every prescription is also reviewed by a licensed Marrow physician before dispensing.
Can I switch from semaglutide to compounded tirzepatide?
Yes. Many patients start with semaglutide and switch to tirzepatide for greater weight loss or if they plateau. Your Marrow physician manages the transition, typically with a short washout period followed by gradual re-titration starting at tirzepatide 2.5mg weekly. Most patients transition smoothly within 2-3 weeks.
Start compounded tirzepatide for $339/mo
21% average weight loss. FDA-registered 503B pharmacy. Physician review within 24 hours.
Start your intake →